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Abstract
 
Lymphoid tissue development is associated with local accumulation of CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi
 
hematopoietic cells that deliver lymphotoxin (LT)
 
 
 
1
 
 
 
2 signals to resident stromal cells. Previ-
ous studies have established an important role for CXCL13 (BLC) in the development of
Peyer’s patches (PP) and some peripheral lymph nodes (LNs), but the chemokine requirements
for several LN types, including mesenteric LNs, remain undefined. Using CXCL13
 
 
 
/
 
  
 
mice
that additionally carry the paucity of LN T cell mutation (
 
plt/plt
 
), we discovered that CCR7
ligands function in peripheral LN development. We also tested for a genetic interaction during
LN development between CXCL13 and a cytokine receptor required in PP development,
IL-7R
 
 
 
. Mice deficient for both CXCL13 and IL-7R
 
  
 
displayed a striking absence of LNs,
including mesenteric LNs. These data extend the role of CXCL13 to the development of all
LNs and establish a previously unappreciated role for IL-7R
 
  
 
in this process. Both circulating
and LN CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi 
 
cells are shown to express LT
 
 
 
1
 
 
 
2 in an IL-7R
 
 
 
–dependent
manner. Furthermore, CXCL13 was found to be sufficient to mediate CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi
 
cell recruitment in vivo to an ectopic site. These findings indicate that CXCL13 and CCR7
ligands promote accumulation of CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi 
 
cells, delivering IL-7R
 
 
 
–dependent
LT
 
 
 
1
 
 
 
2 signals critical for LN development.
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Introduction
 
Genetic studies have identified a key requirement for
membrane-bound lymphotoxin (LT)
 
 
 
1
 
 
 
2 and the LT
 
 
 
receptor (LT
 
 
 
R) in the development of LNs and Peyer’s
patches (PPs; 1). Evidence from a series of experiments has
implicated a population of hematopoietic cells, commonly
termed CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi 
 
cells, as the critical source of
LT
 
 
 
1
 
 
 
2 during lymphoid tissue development (2–5). These
cells are found to colonize sites of future PP and LN devel-
opment and in addition to LT
 
 
 
1
 
 
 
2, they express CD45,
the integrin 
 
 
 
4
 
 
 
7, and the CXCL13 (BLC) receptor,
CXCR5 (2, 6). When these cells are identified by their ex-
pression of IL-7R
 
  
 
or 
 
 
 
4
 
 
 
7, a related population of CD4
 
 
 
LT
 
 
 
1
 
 
 
2
 
  
 
cells is identified in similar numbers (6). IL-7R
 
 
 
is critical for the development of PPs, and this is thought
 
to be due at least in part to its role in inducing LT
 
 
 
1
 
 
 
2
 
on CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi 
 
cells in the PP anlagen (6, 7).
LN development has not yet been reported to require
IL-7R
 
  
 
(8, 9).
The requirement for a circulating cell population to in-
duce LN and PP development indicated a need for
chemoattractant molecules to mediate recruitment and
clustering of the cells at sites of lymphoid tissue genesis.
Consistent with this, CXCL13 and CXCR5 have been
identified as important players in development of periph-
eral LNs and PPs (10, 11). CD4
 
  
 
IL-7R
 
 
 
hi 
 
cells chemotax
to CXCL13 in vitro and a recent study demonstrated that
the transfer of wild-type CD4
 
  
 
CD3
 
  
 
cells to CXCR5-
deficient mice was sufficient to restore some aspects of PP
development (5, 7). However, it is not clear whether
CXCL13 is sufficient to mediate CD4
 
  
 
CD3
 
  
 
IL-7R
 
 
 
hi
 
cell recruitment to sites of lymphoid tissue induction. Fur-
thermore, mesenteric LNs and some other LN types con-
tinue to develop in CXCR5- and CXCL13-deficient mice
and the chemokine requirements for development of these
LNs have not been defined.
Here, we demonstrate that CCL19 (ELC) and/or
CCL21 (SLC) ligands for CCR7 contribute to the induc-
tion of several LN types and we reveal that CXCL13 and
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IL-7R
 
  
 
make overlapping contributions that are essential
for the development of all LNs.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) mice were purchased from Charles
River Laboratories and IL-7R
 
 
 
   
 
, 
 
 
 
c
 
   
 
, and RAG-1
 
    
 
mice
on a B6 background were purchased from Jackson Laboratories.
Rat insulin promoter (RIP)-CXCL13 transgenic mice were on a
B6 background (12). CXCR5
 
    
 
(10) and CXCL13
 
    
 
mice (11)
were backcrossed seven to nine times onto a B6 background. 
 
plt/
plt
 
 mice on a BALB/c background (13) were used to cross with
CXCL13
 
    
 
on a mixed B6/129 background. CXCL13
 
    
 
mice
were screened by PCR on tail DNA as previously described (11).
PCR primers used to type CXCR5
 
    
 
versus CXCR5
 
    
 
mice
were: TGCAAAACTGTGATCGCTCTGC (forward, wild-
type), CTTGACGAGTTCTTCTGAGGGGA (forward, mu-
tant), and AACCTTGGCAAAGAGGAGTTCC (reverse). PCR
primers used to type 
 
 
 
/
 
 
 
, 
 
plt
 
/
 
 
 
, and 
 
plt/plt
 
 were:
ATGGGGTCTAGGAAAACATGG (forward), and AAAT-
TATGAGTATTTCACCTGAGTGTG (reverse). These primers
amplify a sequence polymorphism adjacent to the 
 
plt
 
 locus with a
product of 76 bp for BALB/c mice and 96 bp for B6 mice. The
 
plt
 
 genotype correlated with the presence of a 76-bp band and
was occasionally verified by histology or Western blotting for ab-
sence of CCL21 protein in LNs. Screening of neonatal IL-7R
 
 
 
 
 
/
 
 
 
and IL-7R
 
 
 
    
 
mice was performed on thymus by counting cell
numbers and staining with anti–IL-7R
 
  
 
antibody. All experi-
ments were performed in compliance with institutional guidelines
for animal care.
 
LN Enumeration.
 
Adult mice were injected intraperitoneally
with 300 
 
 
 
l of 1% Chicago sky blue 6B dye (also called Pon-
tamine Blue; Sigma-Aldrich) in PBS 7–14 d before they were
killed. The dye becomes concentrated within lymphoid tissues
and facilitates the macroscopic detection of even very small LNs.
LN nomenclature was performed according to Tilney (14). The
term “cervical LN” refers to LNs that were termed superficial
cervical LNs by Ansel et al. (11) and mandibular LNs by other
authors (15). Periaortic LNs are also called iliac LNs. The chain of
mesenteric LNs was counted as a single LN. All other LN sets
were considered to consist of maximally two nodes, one on each
side of the body axis, even though superficial cervical nodes and
others can consist of pairs of adjacent LNs. “Percentages of LNs
present” were calculated for each LN type using the total number
of LNs found in mice from a given strain relative to the maximal
number of LNs of that type found in the same number of wild-
type B6 mice.
 
Flow Cytometric Analysis and Immunohistochemical Analysis.
 
Embryonic or neonatal mice were killed by decapitation, blood
outflow was collected in Alsever’s solution, and RBCs were lysed
in Tris-ammonium chloride for 1 min. Mesenteric LNs were
identified and removed using a stereomicroscope. LN suspensions
were generated in complete RPMI medium using microscopy
slides and lymphocyte size cells were counted using a hematocy-
tometer. To detect surface expression of LT
 
 
 
1
 
 
 
2, cells were pre-
treated with FcR blocking antibody (2.4.G2; BD Biosciences),
0.5% normal mouse and rat serum, and if indicated, anti-LT
 
 
 
blocking antibody (BB.F6; reference 16). LT
 
 
 
R-Fc (16) was
added and detected using a biotinylated goat anti–human IgG
(Jackson ImmunoResearch Laboratories) pretreated for 30 min
with 4% normal mouse and rat serum. Finally, streptavidin-allo-
phycocyanin (Molecular Probes) was added along with other sur-
face markers. FITC-conjugated antibodies to B220, CD11b (Cal-
 
tag), CD11c, and CD3 (BD Biosciences) were used to identify
lineage-positive cells. PE-labeled antibodies to 
 
 
 
4
 
 
 
7 (DATK32)
or IL-7R
 
  
 
(SB/14) along with PerCP-conjugated anti-CD4
(RM4-5; BD Biosciences) was used to stain for CD4
 
  
 
CD3
 
 
 
cells. To detect CCR7 expression, cells were resensitized for 30
min at 37
 
 
 
C and then stained with CCL19-Fc (17) or hLFA3-Fc
(16) as described above for LT
 
 
 
R-Fc. To detect CXCR5 ex-
pression, cells were stained with CXCR5 rabbit antiserum (17) in
4% normal mouse and rat serum, followed by biotinylated goat
anti–rabbit IgG (BD Biosciences) and streptavidin-allophycocya-
nin. Stained cells were analyzed using a four-color FACSCali-
bur
 
® 
 
(BD Biosciences) and FlowJo
 
® 
 
software (BD Biosciences).
Flow cytometric and immunohistochemical analysis of nonper-
fused embryonic/newborn pancreas was performed as previously
described for adult pancreas (12).
 
Quantitative RT-PCR Analysis.
 
PCR primers and probes for
CCL19, CCL21, and HPRT were as previously described (18).
PCR primers were specific for CCL19-atg but did not distin-
guish between CCL21-ser and CCL21-leu. Additional primer
pairs and probes, including their specificity, orientation (forward
[F], reverse [R]), and sequence were as follows: CXCL13 (F tg-
gccagctgcctctctc, R ttgaaatcactccagaacacctaca, probe aggccacgg-
tattctggaagcccat). Quantitative RT-PCR was performed on an
ABI7700 sequence detection instrument (Taqman; Applied Bio-
systems) according to the manufacturer’s instructions.
 
Online Supplemental Material.
 
Fig. S1 shows photographs of
inguinal LN regions in wild-type, IL-7R
 
 
 
 
 
/
 
 
 
, RAG-1
 
 
 
/
 
 
 
,
CXCL13
 
 
 
/
 
 
 
, and CXCL13
 
 
 
/
 
 
 
 IL-7R
 
 
 
 /  mice. Fig. S1 is
available at http://www.jem.org/cgi/content/full/jem.20021294
/DC1.
Results
CCR7 Ligands Function in LN Development. The fail-
ure of LN development in CXCL13 /  and CXCR5 / 
mice is characterized by variable, incomplete penetrance
for affected LNs and consistent development of mesenteric
LNs (11, 19). Previous studies have indicated that CD4 
CD3   cells from embryonic intestine express CCR7
mRNA and chemotax to CCL19 (ELC) and CCL21
(SLC) in addition to CXCL13 (7), and we find that CD4 
CD3  IL-7R hi cells from embryonic mesenteric LNs are
uniformly positive for CCL19-Fc binding as well as for ex-
pressing CXCR5 (Fig. 1 A). In previous work, we have
established that CCL19-Fc is a faithful reporter of CCR7
expression levels on lymphoid cells (17). CD4  CD3  IL-
7R hi cells showed weaker staining for both CCR7 and
CXCR5 compared with the CD4  subset (Fig. 1 A). Con-
sistent with CCL19 and CCL21 participating in early
events during LN development, mRNA for these chemo-
kines as well as for CXCL13 was found at high levels in
the mesenteric region of embryonic day (E) 17.5 mice
(Fig. 1 B). CCR7-deficient mice and plt/plt mice that lack
the CCL19 gene and the CCL21-ser gene have not previ-
ously been found to lack LNs or PPs (13, 20–22). How-
ever, we have observed the occasional absence of inguinal
LNs in plt/plt and CCR7    mice and a single case of axil-
lary LN deficiency in plt/plt mice (Fig. 1 C and not de-
picted). To test the possibility that the contribution of
CCR7 ligands to LN development was partially overlap-T
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ping with CXCL13, we intercrossed plt/plt mice with
mice carrying a targeted deletion of the CXCL13 gene
(11). CXCL13    plt/plt mice were found to display a
markedly greater LN deficiency than observed in
CXCL13    mice, with frequent absence of facial and cer-
vical LNs (Fig. 1 C). CXCL13    plt/plt mice also exhib-
ited a more complete deficiency in brachial and axillary
LNs than CXCL13    mice. By contrast, mesenteric LNs
continued to develop in these multi-chemokine–deficient
mice (Fig. 1 C). These observations establish that CCR7
ligands have a broad role in LN development that partially
overlaps with the role of CXCL13.
IL-7R -dependent LT 1 2 Expression by CD4  CD3 
IL-7R hi Cells in LNs and in Blood. A key function of
CD4   CD3   cells is thought to be the provision of
LT 1 2 signals necessary for LN and PP development (1).
IL-7R   functions in PP development by inducing
LT 1 2 on CD4  CD3  cells (6, 7), and we previously
observed that CXCL13 up-regulates LT 1 2 on B cells
(11). Therefore, we reasoned that IL-7R  and CXCL13
may both contribute to LT 1 2 induction in LN CD3 
IL-7R hi cells. LT 1 2 levels were measured on cells
from newborn (day 0.5) IL-7R     and CXCL13    or
CXCR5    mesenteric LNs. To facilitate identification of
CD4  CD3  cells in IL-7R     mice,  4 7 was used as a
marker in place of IL-7R  (2, 6). CD4  CD3   4 7  cells
from mesenteric LNs of IL-7R     mice showed strongly
decreased staining with LT R-Fc compared with wild-
type cells (Fig. 2, A and B) although the staining remained
above the background level determined by pretreatment of
cells with an LT -specific antibody that blocks LT R-Fc
binding to LT 1 2 (Fig. 2 A). CD4  CD3   4 7  cells
exhibited bimodular staining with LT R-Fc and their fre-
quency in IL-7R     mice was too low to allow reliable
measurement of LT 1 2 levels (not depicted). Analysis of
cells from CXCR5    mice showed LT 1 2 expression
levels close to the wild-type control (Fig. 2, A and B). In
agreement with the in vivo observations, in vitro exposure
of CD4  CD3   4 7  and CD4  CD3   4 7  cells from
embryonic mesenteric LNs to IL-7 was sufficient to pro-
mote up-regulation of LT 1 2 (Fig. 2 C and not de-
picted). By contrast, CXCL13 did not lead to a detectable
up-regulation of LT R-Fc staining although the high con-
stitutive expression of LT 1 2 on CD4  CD3   4 7 
cells in the absence of chemokine or cytokine addition may
have obscured small effects of CXCL13 (Fig. 2 C). To ex-
amine at which step LT 1 2 induction occurs in vivo, we
asked whether a difference in LT 1 2 expression could be
observed between CD4  CD3   4 7  cells in blood versus
mesenteric LNs. Surprisingly, we observed levels of surface
LT 1 2 expression on circulating CD4  CD3   4 7 
cells that were similar to those on cells in mesenteric LNs
and this expression was also partially dependent on IL-7R 
(Fig. 2, A and D) but not CXCR5 (Fig. 2, A and D).
Mice with Combined Deficiency for CXCL13 and IL-7R 
Lack all LNs. The substantial reduction in LT 1 2 ex-
pression on CD4  CD3   4 7  cells of IL-7R     mice
prompted us to investigate the presence of LNs in these
mice. Although earlier studies have not reported a LN de-
ficiency in IL-7R –deficient mice (8, 9), we observed
that about half of the IL-7R  single–deficient mice we
analyzed lacked one or both macroscopically detectable
axillary, periaortic, inguinal, and cervical LNs (Fig. 3 A).
The LNs that remained in these animals were often very
small, typically smaller than those present in lympho-
cyte-deficient RAG-1 /  mice (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20021294/DC1). Mi-
croscopic examination of sites lacking LNs revealed the
occasional presence of rudimentary lymphoid nodules
(Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20021294/DC1, and not depicted). The pres-
ence of facial and mesenteric LNs was largely unaffected
by IL-7R  deficiency although their size was clearly re-
duced (Fig. 3, A and C, and not depicted). Analysis of
mice deficient in the IL-2R common   chain ( c) that is
Figure 1. The chemokines CXCL13 (BLC), CCL19 (ELC), and
CCL21 (SLC) play overlapping roles in the development of facial, cervi-
cal, brachial, and axillary LNs. (A) Representative histograms showing the
staining with CCL19-Fc fusion protein (left) or CXCR5 on the CD4 
(shaded) and CD4  (open) subset of CD3  IL-7R hi cells from E 18.5
mesenteric LNs (mLN) of wild-type mice. As a negative control, staining
with the fusion protein hLFA3-Fc is shown for embryonic CD4  CD3 
IL-7R hi cells (left) and CXCR5 staining is shown for CD4  CD3 
IL-7R   triple negative cells (TN, right) in dotted lines. CD3  indicates
low or negative for the lineage markers B220, CD3, CD11c, and CD11b.
(B) Quantitative PCR analysis of chemokine expression in the indicated
organs from E17.5 B6 mice. As negative controls, mesenteric LN samples
from adult CCL19/CCL21-ser (plt/plt) or CXCL13-deficient mice were
used. CCL21 expression in fetal heart and the weak expression in fetal
liver and in plt/plt mesenteric LNs is likely due to lymphatic expression of
the second CCL21 gene, CCL21-leu. Three samples were analyzed per
group except for the CXCL13    mesenteric LN. ND, not determined.
(C) Quantitative assessment of the presence of the indicated LN types de-
tected macroscopically after injection of Chicago sky blue dye (refer to
Materials and Methods) in littermate mice deficient for CCL19/CCL21-ser
(plt/plt), CXCL13, or CCL19/CCL21-ser and CXCL13 combined. 10–13
mice were investigated per group.T
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1194 Chemokine and Cytokine Requirements for Lymph Node Development
required for signaling by several cytokine receptors, in-
cluding the IL-7 receptor, revealed a similar deficiency in
LNs (Fig. 3 A).
To explore whether IL-7R  and CXCL13 contribute to
the same process in LN development, mice with combined
IL-7R  and CXCL13 deficiency were investigated. Strik-
ingly, all seven LN types investigated were absent in these
mice, including facial and mesenteric LNs, with the excep-
tion of a single animal that retained a periaortic LN (Fig. 3,
B and C, and Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20021294/DC1). Enumeration of
CD3   4 7  cells in day 0.5 mesenteric LNs revealed that
they were reduced in IL-7R      mice but not in
CXCR5    or CXCL13    mice (Fig. 4, A and B, and not
depicted). Consistent with a very early block in mesenteric
LN development in CXCL13    IL-7R     mice, CD3 
 4 7  cells were almost absent in the mesenteric region of
day 0.5 animals (Fig. 4, A and B). Analysis of CD3   4 7 
cell frequencies in newborn blood showed that wild-type,
IL-7R    , CXCR5   , and CXCL13    mice had low
but comparable frequencies whereas in CXCL13    IL-
7R     mice their frequency was slightly increased (Fig. 4
C and not depicted). These findings indicate that CXCL13
and IL-7R  make overlapping contributions that are criti-
cal for appropriate accumulation of CD3  IL-7R hi cells
during LN development.
Figure 2. IL-7R  but not CXCR5 signals promote in-
duction of LT 1 2 on CD4  CD3   4 7  cells in devel-
oping mesenteric LNs and in blood. (A) Representative
histograms showing LT R-Fc staining on CD4  CD3 
 4 7  cells from day 0.5 mesenteric LNs (mLN) or blood
of wild-type (wt) or CXCR5    (shaded) and IL-7R    
or CXCR5    mice (solid) as indicated. As a negative con-
trol, LT R-Fc staining of wild-type cells pretreated with
anti-LT  blocking antibody is shown (dotted line). (B)
Compilation of data as shown in A, showing the mean
fluorescence intensity (MFI) of LT R-Fc staining on
CD4  CD3   4 7  cells from mesenteric LNs of new-
born mice of the indicated genotypes. (C) LT R-Fc stain-
ing of sorted CD4  CD3   4 7  cells from mesenteric
LN cells of E18.5 mice that had been cultured for 6 h in
vitro without treatment (nil, shaded), with 2  g/ml
CXCL13 (thin dotted line), or with 20 ng/ml IL-7 (open).
As a negative control, LT R-Fc staining of wild-type cells
treated with anti-LT  blocking antibody is shown (thick
dotted line). CD3  indicates low or negative for the lin-
eage markers B220, CD3, CD11c, and CD11b. Data are
representative of two experiments. Similar observations were made for CD4  CD3   4 7  cells in the same cultures. (D) Compilation of data as in A,
showing the MFI of LT R-Fc staining on CD4  CD3   4 7  cells from blood of newborn mice of the indicated genotypes. In B and D, plotted values
represent the MFI after subtraction of the background LT R-Fc staining on cells treated with LT  blocking antibody. The data are compiled from two
to four independent experiments, with littermate mice used as controls. IL-7R     mice were either CXCL13    or CXCL13   , and data were pooled
as no difference was observed between these two groups.
Figure 3. Deficiency of macroscopically detectable LNs in IL-7R    
and IL-7R     CXCL13    mice. (A and B) Quantitative assessment of
the presence of the indicated LNs in mice deficient for IL-7R ,  c chain,
RAG-1 (A), CXCL13, or IL-7R  and CXCL13 combined (B), com-
pared with wild-type levels (100%). Importantly, with the exception of
one periaortic LN, all LNs were missing in IL-7R     CXCL13    mice.
The LN enumeration data for CXCL13    mice is equivalent to that pre-
viously reported (reference 11) and is shown here to facilitate the com-
parison with the other mouse strains. No difference in LN presence was
observed between IL-7R     CXCL13    and IL-7R     CXCL13   
mice. 100% of IL-7R     mice also lacked sacral LNs (not depicted). The
n value indicates the number of mice that were investigated using Chi-
cago sky blue dye. (C) Representative photograph of mesentery region in
IL-7R     CXCL13    and IL-7R     CXCL13    mice that had been
injected with Chicago sky blue dye, showing the presence of several small
mesenteric LNs in IL-7R     CXCL13    mice (arrow heads) and the
absence of detectable mesenteric LNs in IL-7R     CXCL13    mice.T
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1195 Luther et al. Brief Definitive Report
Accumulation of CD4  IL-7R hi Cells in Pancreatic Islets of
RIP-CXCL13 Mice. Previous studies have demonstrated
that ectopic expression of CXCL13 in the pancreatic islets
leads to recruitment of B and T lymphocytes in large
numbers (12). To determine whether CXCL13 was suffi-
cient to mediate recruitment of CD4  CD3  IL-7R hi
cells, we analyzed the pancreas of RIP-CXCL13 trans-
genic mice at E 18.5, a time when few T or B lympho-
cytes are present in circulation. As expected from previous
studies of RIP activity, CXCL13 transgene expression
was detected in the fetal pancreas of transgenic but not
control mice (Fig. 5 A, insets). Immunohistochemical
staining for CD4 revealed the presence of numerous
CD4  cells in the pancreas of transgenic but not control
mice, with most of the cells situated proximal to the
CXCL13-expressing islet cells (Fig. 5 A). No CD3  cells
could be identified in the pancreas at this time (not de-
picted). Flow cytometric analysis confirmed the presence
of CD4  CD3  IL-7R hi cells in the pancreas of trans-
genic mice and revealed their frequency to be  20-fold
above the background level detected in littermate controls
(Fig. 5 B). CD4  IL-7R hi cells were also detected in the
transgenic pancreas, although at a lower frequency than
the CD4  subset (Fig. 5 B) consistent with their lower ex-
pression of CXCR5 (Fig. 1 A). These findings support
the conclusion that CXCL13 plays a direct role in pro-
moting the accumulation of CD4  CD3  IL-7R hi cells
in nascent LNs.
Discussion
The above observations establish that CCR7 ligands
function in the development of several LN types and that
CXCL13 (BLC) and IL-7R  function in the development
of all LNs. In the case of peripheral LNs, CXCL13 and IL-
7R  each play such a strong role that mice lacking either
molecule fail to develop some of their LNs. Deficiency in
mesenteric, cervical, and facial LNs becomes evident only
when both molecules are absent, indicating overlapping
contributions by the CXCL13 and IL-7R  pathways. We
also demonstrate that IL-7R –dependent signals promote
LT 1 2 expression on circulating CD4  CD3  cells and
that CXCL13 mediates in vivo recruitment of these
LT 1 2-expressing cells.
The finding that CCL21 (SLC) and/or CCL19 (ELC)
function in the development of facial, cervical, brachial, and
axillary LNs provides the second example of chemokine re-
ceptor involvement in lymphoid tissue organogenesis. An
initial indication that CCR7 may function in lymphoid tis-
sue development came from the observation that CD4 
CD3  IL-7R hi cells from embryonic intestine can respond
to CCL19 and CCL21, and that CCL19 was up-regulated
at an early step during PP development in an IL-7R –
dependent manner (7). As CD4  CD3  cells express both
CXCR5 and CCR7 and respond similarly in vitro to
CXCL13, CCL19, and CCL21, we suggest that these mol-
ecules may function at a similar early step in LN develop-
ment, such as in the recruitment and clustering of CD4 
Figure 4. IL-7R  and CXCR5 signals promote the
accumulation of CD3   4 7  cells in developing mesen-
teric LNs. (A) Representative dot plots of day 0.5 mesen-
teric LNs or mesentery region from wild-type, IL-7R    ,
and IL-7R     CXCL13    mice showing reduced num-
bers and absence of CD3   4 7  cells in IL-7R     and
IL-7R     CXCL13    mice, respectively. (B) Histograms
depicting the number of CD3   4 7  cells per mesenteric
LN of newborn mice of the genotype indicated. In each
case, 40% of CD3   4 7  cells were CD4 . (C) Histo-
gram showing the percentage of CD3   4 7  cells in pe-
ripheral blood leukocytes of newborn mice of the genotype
indicated. n, number of mice investigated. Each set is a
compilation of two to three different experiments, with lit-
termate mice used as controls. In B and C, CD3  indicates
low or negative for the lineage markers B220, CD3,
CD11c, and CD11b except for IL-7R     mice (B) where
only B220, CD3, and CD11c were used as lineage markers.
Figure 5. CD4   IL-7R hi
cells in the pancreas of RIP-
CXCL13 transgenic mice. (A)
Immunohistochemical analysis
of pancreas from RIP-CXCL13
transgenic (tg ) and littermate
control (tg ) E 18.5 embryos to
detect insulin-producing   cells
(blue) and CD4  cells (brown).
Insets, adjacent sections stained
to detect CXCL13 transgene
expression (blue). (B) Frequency
of IL-7R hi CD3  B220  cells in day 1.5 pancreas tissue of transgenic and littermate control mice. Numbers show average percentages of CD4  and
CD4  IL-7R hi cells   standard deviation in seven tg  and five tg  mice.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
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CD3  cells, with CXCL13 playing the dominant role. The
continued ability of CXCL13    plt/plt mice to develop
some LN types, including mesenteric LNs, might reflect the
incomplete deficiency of CCL21 in plt/plt mice because this
spontaneous mutant mouse strain retains lymphatic CCL21
expression (21). As the plt mutation arose by a spontaneous
deletion, it is formally possible that the LN development
defect we observed reflects the role of some other gene that
was disrupted by the deletion, although the finding of simi-
lar peripheral LN deficiencies in plt/plt and CCR7    mice
makes this unlikely. Analysis of CXCR5/CCR7 double
deficient mice should help to further address this issue. Our
studies leave open the possibility that additional chemokine
receptors, such as CXCR4 (5), participate in inducing re-
cruitment and adhesion of CD3  IL-7R hi cells, particularly
during mesenteric LN development.
Previous experiments have established a critical role for
the IL-7R  chain in PP but not LN development (8, 9,
23). The finding that IL-7R     mice lack a fraction of
their axillary, inguinal, periaortic, and cervical LNs demon-
strates that this receptor has an important nonredundant
role in LN organogenesis. Mice deficient in the IL2R c
chain, which partners with IL-7R  in the IL-7 receptor
but not the TSLP receptor (24), have been suggested to
have a partial deficiency in some peripheral LNs (25) and
our findings confirm and extend this observation. Similarly,
mice deficient in the tyrosine kinase jak-3 that transmits
signals by  c chain–containing receptors have been shown
to lack some peripheral but not mesenteric LNs (26). By
showing that lymphocyte-deficient RAG-1    mice re-
tained all seven LN types analyzed, we have excluded that
the LN deficiencies in the IL-7R  and  c mutants is due to
the role of IL-7 receptor signaling in lymphocyte develop-
ment. Although the extent of LN deficiency in IL-7 / 
mice has not yet been established (27), the present findings
suggest that the IL-7R  requirement in LN development is
due to its involvement in IL-7R / c heterodimers that
transmit signals in response to IL-7.
The consistently smaller LN size in IL-7R     com-
pared with RAG-1    mice (see Fig. S1, available at http:
//www.jem.org/cgi/content/full/jem.20021294/DC1) in-
dicates that IL-7R  signaling may have a more general role
in LN development than indicated by the measurement of
LN presence or absence. In this regard it is important to
note that IL-7R  deficiency, but not CXCR5 or CXCL13
deficiency, led to decreased numbers of CD3   4 7  cells
in mesenteric LNs at birth. IL-7R  deficiency did not have
a significant effect on the frequency of these cells in new-
born blood, suggesting that this pathway was required for
the cells to accumulate within the developing mesenteric
LN. As the IL-7R  signal was important for promoting
maximal expression of LT 1 2 on CD4  CD3   4 7 
cells, a likely explanation is that the accumulation of CD3 
 4 7  cells is the result of ongoing recruitment, and the
lower LT 1 2 expression on CD4  CD3   4 7  cells in
the absence of IL-7R  results in weaker induction of che-
mokines and adhesion molecules needed for cell recruit-
ment or retention (6, 7). Consistent with this possibility,
the accumulation of CD4  CD3  cells is reduced to a sim-
ilar extent in the mesenteric region of newborn IL-7R    
mice (Fig. 4) as in LT     mice (28). IL-7R  signals could
also be involved in proliferation or survival of CD3 
 4 7  cells, similar to the role of this pathway in lympho-
cyte development. It remains to be determined whether
the reduced LT 1 2 expression or reduced numbers of
CD4  CD3  cells are sufficient to explain the small LN size
in IL-7R  /  mice, or whether IL-7R  signaling has addi-
tional functions necessary for LN development.
In experiments to determine whether a local source of
IL-7R  ligand is responsible for the induction of LT 1 2
in CD4  CD3   4 7  cells during LN development, we
observed similar levels of LT 1 2 expression on CD4 
CD3   4 7  cells from blood compared with mesenteric
LNs. This finding suggests that CD4  CD3   4 7  cells
are induced to express LT 1 2 before entry into early
LNs. This possibility is consistent with the lack of evidence
for focal expression of IL-7R  ligands in developing PPs
(6, 7) and with the observation that transgenic expression
of IL-7 diffusely within intestinal enterocytes is sufficient to
partially restore defective PP development in IL-7 /  mice
(29). In further support of a systemic action for IL-7R 
ligands, a recent study showed rescue of LN development
in TRAF6    mice by intraembryonic IL-7 injection (30).
Although IL-7R  signals play a major role in LT 1 2
induction on mesenteric CD4  CD3  IL-7R hi cells, a
considerable level of LT 1 2 remains on these cells in the
absence of IL-7R  (Fig. 2, A and B), implicating the in-
volvement of other LT 1 2-inducing signals. Our studies
fail to establish a role for CXCL13 in mediating LT 1 2
induction in these cells, although a small contribution by
CXCL13 is not excluded. TRANCE and TRANCE re-
ceptor, which are both expressed on CD4  CD3  IL-
7R hi cells, play a critical role in the development of LNs
but not PPs (28), and a recent study demonstrated in vitro
that TRANCE receptor signaling via TRAF6 induces
LT 1 2 expression CD4  CD3  cells (30). Although this
study establishes an important role for TRAF6-dependent
signals in induction of LT 1 2, TRAF6    CD4  CD3 
cells retained detectable LT 1 2 expression (30). This ob-
servation is consistent with our finding that IL-7R  signal-
ing contributes to the induction of LT 1 2 on CD4 
CD3  cells found in developing mesenteric LNs and there-
fore we propose that both IL-7R  signaling and TRANCE
receptor signaling contribute to LT 1 2 induction during
LN development.
Our findings are consistent with the possibility that
CXCL13 is needed for efficient recruitment and/or clus-
tering of IL-7R hi lymphoid tissue–inducing cells in the
earliest LN anlagen and that IL-7R  is needed for maximal
expression of LT 1 2 on these cells. In the absence
of CXCL13, other chemokines, including CCL21 and
CCL19, may recruit sufficient IL-7R hi cells to the mesen-
teric LN anlagen such that the necessary LT 1 2 signaling
is provided for events to proceed. When mice lack IL-
7R , the lymphoid tissue–inducing cells have reduced
amounts of LT 1 2 expression and the combined actionT
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of CXCL13 and additional chemokines might be able to
recruit/cluster enough of the cells to ensure a sufficient
LT 1 2 signal is provided for development to proceed.
We propose that when both CXCL13 and IL-7R  are
lacking, the combined effect of reduced cell recruitment/
clustering and reduced LT 1 2 expression on each cell re-
sults in insufficient LT 1 2 signaling for LN development.
Thus, we establish for the first time the broad contribution
of CXCL13 and IL-7R  signaling to the development of
all LNs and we suggest that although these molecules make
distinct contributions, their ultimate contribution to the
provision of LT 1 2 is partially redundant. Finally, our
experiments establish that CCR7 ligands contribute to the
development of peripheral and cervical LNs.
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